Submitted by Anonymous (not verified) on 19 February 2026 - 13:00
Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Adzynma, rADAMTS13, Date of authorisation: 01/08/2024, Revision: 1, Status: Authorised